Skip to content

FCPM III SERVICES B.V.

Follow

13F filer, CIK 2013410, NAARDEN, Netherlands

FCPM III SERVICES B.V. reported $1,060,669,027 across 15 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 96.41% of the portfolio.

Accepted , ingested 13F-HR 0001193125-26-462149

Period
2026-09-30
Reported value
$1.06B
Holdings
15
Top 10 weight
96.41%
New
4
Sold out
0

Part of the filer group FCPM III SERVICES B.V.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BRVEnew+21,826,024$441M
KRSAnew+2,192,155$70.1M
MPLTadded+1,201,928$12.2M
AURAadded+1,195,066$7.51M
TARSnew+64,087$5.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
REPLreduced-1,087,868-$14.4M
VORreduced-712,075-$13.6M
DYNreduced-261,460-$4.21M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-462149, largest first. % of portfolio is the value over $1,060,669,027, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 21,826,024 shares 21,826,024$441M41.57%newTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,597,181 shares; 2025Q1: 10,935,310 shares; 2025Q2: 10,632,113 shares; 2025Q3: 9,212,384 shares; 2025Q4: 9,198,900 shares; 2026Q1: 9,198,900 shares; 2026Q2: 8,490,353 shares; 2026Q3: 8,490,353 shares 8,490,353$206M19.47%0Timeline
KRSAKORSANA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,192,155 shares 2,192,155$70.1M6.61%newTimeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 379,640 shares; 2025Q4: 3,617,354 shares; 2026Q1: 4,117,354 shares; 2026Q2: 4,117,354 shares; 2026Q3: 3,405,279 shares 3,405,279$65M6.13%-712,075Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,462,846 shares; 2025Q1: 5,462,846 shares; 2025Q2: 5,462,846 shares; 2025Q3: 5,462,846 shares; 2025Q4: 5,462,846 shares; 2026Q1: 4,644,386 shares; 2026Q2: 3,848,256 shares; 2026Q3: 3,586,796 shares 3,586,796$57.8M5.45%-261,460Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,441,000 shares; 2026Q2: 2,441,000 shares; 2026Q3: 2,441,000 shares 2,441,000$51.9M4.9%0Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,226,400 shares; 2026Q1: 3,226,400 shares; 2026Q2: 3,226,400 shares; 2026Q3: 4,428,328 shares 4,428,328$45.1M4.25%+1,201,928Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,053,775 shares; 2026Q3: 5,248,841 shares 5,248,841$33M3.11%+1,195,066Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,677,852 shares; 2026Q1: 1,677,852 shares; 2026Q2: 1,677,852 shares; 2026Q3: 2,022,679 shares 2,022,679$29.5M2.78%+344,827Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,970,668 shares; 2025Q1: 3,909,696 shares; 2025Q2: 3,909,696 shares; 2025Q3: 4,158,368 shares; 2025Q4: 2,808,368 shares; 2026Q1: 2,808,368 shares; 2026Q2: 2,808,368 shares; 2026Q3: 1,720,500 shares 1,720,500$22.8M2.15%-1,087,868Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,632,561 shares; 2025Q1: 9,632,561 shares; 2025Q2: 9,632,561 shares; 2025Q3: 9,632,561 shares; 2025Q4: 9,632,561 shares; 2026Q1: 9,632,561 shares; 2026Q2: 9,632,561 shares; 2026Q3: 9,632,561 shares 9,632,561$19.3M1.82%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,452,330 shares; 2025Q1: 3,452,330 shares; 2025Q2: 3,452,330 shares; 2025Q3: 3,452,330 shares; 2025Q4: 3,468,430 shares; 2026Q1: 3,468,430 shares; 2026Q2: 3,468,430 shares; 2026Q3: 3,468,430 shares 3,468,430$12.8M1.2%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 64,087 shares 64,087$5.04M0.47%newTimeline
ENGNWENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,878,148 shares; 2025Q1: 2,878,148 shares; 2025Q2: 2,878,148 shares; 2025Q3: 2,878,148 shares; 2025Q4: 2,878,148 shares; 2026Q1: 2,878,148 shares; 2026Q2: 2,878,148 shares; 2026Q3: 2,878,148 shares 2,878,148$576K0.05%0Timeline
LSTALISATA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 297,478 shares 297,478$428K0.04%newTimeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-462149 base2026-11-16